Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
12.32 EUR | -1.60% | -3.75% | +25.46% |
May. 20 | BTIG Initiates Abivax at Buy Rating With $43 Price Target | MT |
May. 08 | Abivax: four abstracts to be presented on obefazimod | CF |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
858M | - | |||||
56.65B | - | |||||
39.44B | ||||||
39.03B | ||||||
26.86B | ||||||
26.75B |
- Stock Market
- Equities
- ABVX Stock
- Charts Abivax
- Sector Chart